Singapore, Aug. 15 -- A research team from Hong Kong Baptist University (HKBU) has successfully developed a "Sequential Measurement Based Multi-Parameter Microfluidic Flow Cytomolecular Analyser" (referred to as the "Microfluidic Flow Cytomolecular Analyser"), which leverages innovative technology to significantly improve testing efficiency. It also reduces costs to only one-tenth to one-fifth of similar products in the market so as to benefit more patients.

The project was recently awarded funding under the "Research, Academic and Industry Sectors One-plus Scheme" (RAISe+ Scheme) launched by the Innovation and Technology Commission of the Hong Kong Special Administrative Region Government to support the commercialisation of its research...